California State Teachers Retirement System Cuts Position in Omnicell, Inc. (OMCL)

California State Teachers Retirement System reduced its stake in shares of Omnicell, Inc. (NASDAQ:OMCL) by 9.7% in the 3rd quarter, Holdings Channel reports. The firm owned 58,822 shares of the company’s stock after selling 6,298 shares during the quarter. California State Teachers Retirement System’s holdings in Omnicell were worth $3,003,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Riverhead Capital Management LLC grew its stake in Omnicell by 76.3% in the 2nd quarter. Riverhead Capital Management LLC now owns 4,230 shares of the company’s stock worth $182,000 after acquiring an additional 1,830 shares during the period. Flinton Capital Management LLC grew its stake in Omnicell by 74.6% in the 2nd quarter. Flinton Capital Management LLC now owns 4,216 shares of the company’s stock worth $182,000 after acquiring an additional 1,802 shares during the period. Pinebridge Investments L.P. grew its stake in Omnicell by 1.6% in the 2nd quarter. Pinebridge Investments L.P. now owns 4,896 shares of the company’s stock worth $211,000 after acquiring an additional 76 shares during the period. Amalgamated Bank purchased a new stake in Omnicell in the 2nd quarter worth approximately $219,000. Finally, Stevens Capital Management LP purchased a new stake in Omnicell in the 3rd quarter worth approximately $305,000. Hedge funds and other institutional investors own 99.61% of the company’s stock.

Shares of Omnicell, Inc. (OMCL) opened at $50.45 on Friday. Omnicell, Inc. has a 12 month low of $32.10 and a 12 month high of $55.40. The stock has a market cap of $1,910.00, a price-to-earnings ratio of -458.64, a PEG ratio of 4.00 and a beta of 0.71. The company has a current ratio of 1.53, a quick ratio of 1.08 and a debt-to-equity ratio of 0.38.

Omnicell (NASDAQ:OMCL) last announced its quarterly earnings data on Thursday, October 26th. The company reported $0.42 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.42. Omnicell had a negative net margin of 0.51% and a negative return on equity of 0.79%. The company had revenue of $186.78 million during the quarter, compared to analysts’ expectations of $192.45 million. During the same period in the previous year, the company earned $0.40 EPS. The business’s quarterly revenue was up 5.7% compared to the same quarter last year. sell-side analysts predict that Omnicell, Inc. will post 0.12 earnings per share for the current fiscal year.

Several analysts have commented on OMCL shares. Cantor Fitzgerald lifted their target price on shares of Omnicell to $58.00 and gave the stock an “overweight” rating in a research note on Friday, October 27th. Zacks Investment Research cut shares of Omnicell from a “hold” rating to a “strong sell” rating in a research note on Wednesday, November 1st. Oppenheimer reaffirmed a “buy” rating and issued a $55.00 target price on shares of Omnicell in a research note on Thursday, October 19th. Craig Hallum reaffirmed a “buy” rating and issued a $62.00 target price (up from $52.00) on shares of Omnicell in a research note on Monday, October 30th. Finally, BidaskClub cut shares of Omnicell from a “hold” rating to a “sell” rating in a research note on Friday, December 22nd. Two analysts have rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $55.14.

In other news, CFO Peter J. Kuipers sold 1,926 shares of the business’s stock in a transaction on Monday, December 18th. The shares were sold at an average price of $51.69, for a total transaction of $99,554.94. Following the completion of the sale, the chief financial officer now directly owns 40,544 shares of the company’s stock, valued at approximately $2,095,719.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Dan S. Johnston sold 14,613 shares of the business’s stock in a transaction on Friday, November 17th. The shares were sold at an average price of $47.81, for a total transaction of $698,647.53. Following the sale, the executive vice president now directly owns 43,621 shares of the company’s stock, valued at $2,085,520.01. The disclosure for this sale can be found here. Insiders have sold a total of 27,558 shares of company stock valued at $1,330,230 over the last three months. Corporate insiders own 3.77% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was first reported by Markets Daily and is owned by of Markets Daily. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://www.themarketsdaily.com/2018/01/12/california-state-teachers-retirement-system-cuts-position-in-omnicell-inc-omcl.html.

Omnicell Profile

Omnicell, Inc provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence.

Want to see what other hedge funds are holding OMCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omnicell, Inc. (NASDAQ:OMCL).

Institutional Ownership by Quarter for Omnicell (NASDAQ:OMCL)

Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply